Implications of the severity of social phobia

Journal of Affective Disorders

Volumn 50, Issue SUPPL. 1, 1998, Pages

  Montgomery, Stuart A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Diagnosis; Paroxetine; Severity; Social phobia; SSRIs

Indexed keywords

PAROXETINE; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; MALADJUSTMENT; PRIORITY JOURNAL; SCORING SYSTEM; SOCIAL INTERACTION; SOCIAL ISOLATION; SOCIAL PHOBIA; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PAROXETINE; PERSONALITY INVENTORY; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0031754248     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(98)00093-7     Document Type: Conference Paper

References (20)

1. Cox, B.J., Direnfeld, D.M., Swinson, R.P., Norton, G.R., 1994. Suicidal ideation and suicide attempts in panic disorder and social phobia. Am. J. Psychiatry 151, 882-887.
2. Davidson, J.R.T., Hughes, D.L., George, L.K., Blazer, D.G., 1993. The epidemiology of social phobia: Findings from the Duke Epidemiological Catchment Area Study. Psychol. Med. 23, 709-718.
3. Dunbar, G.C., Cohn, J.B., Fabre, L.F., Feighner, J.P., Fieve, R.R., Mendels, J., Shrivastava, R.K., 1991. A comparison of paroxetine, imipramine and placebo in depressed out-patients. Br. J. Psychiatry 159, 394-398.
4. Dunbar, G.C., Fuell, D.L., 1992. The anti-anxiety and anti-agitation effects of paroxetine in depressed patients. Int. Clin. Psychopharmacol. 6 (S4), 81-90.
5. Dunbar, G.C., Claghorn, J.L., Kiev, A., Rickels, K., Smith, W.T., 1993. A comparison of paroxetine and placebo in depressed outpatients. Br. J. Psychiatry 159, 394-398.
6. Gergel, I., Pitts, C., Gakes, R., Kumar, R., 1997. Significant improvement in symptoms of social phobia after paroxetine treatment. Biol. Psychiatry 42, 26S (Abs. 14-12).
7. Katzelnick, D.J., Kobak, K.A., Greist, J.H., Jefferson, J.W., Mantle, J.M., Serlin, R.C., 1995. Sertraline for social phobia: A double-blind, placebo-controlled crossover study. Am. J. Psychiatry 152, 1368-1371.
8. Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.-U., Kendler, K.S., 1994. Lifetime and 12-month prevalence of DSM-III psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51, 8-19.
9. Lecrubier, Y., Bakker, A., Judge, R. and the Collaborative Paroxetine Study Investigators, 1997. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatr. Scand. 95, 145-152.
10. Marshall, R.D., Schneier, F.R., Fallon, B.A., 1994. Medication therapy for social phobia. J. Clin. Psychiatry 55 (Suppl), 33-37.
11. Montgomery, S.A., 1995. Social Phobia, Science Press, London.
12. Montgomery, S.A., Dunner, D.L., Dunbar, G.C., 1995. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur. Neuropsychopharmacol. 5, 5-13.
13. Nutt, D., Montgomery, S.A., 1996. Moclobemide in the treatment of social phobia. Int. Clin. Psychopharmacol. 11 (Suppl. 3), 77-82.
14. Oehrberg, S., Christiansen, P.E., Behnke, K., Borup, A.L., Severn, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J.K., Manniche, P.M., 1995. Paroxetine in the treatment of panic disorder a randomised, double-blind, placebo-controlled study. Br. J. Psychiatry 167, 374-379.
15. Schneier, F.R., Johnson, J., Horning, C.D., Liebowitz, M.R., Weissman, M.M., 1992. Social phobia: Comorbidity and morbidity in an epidemiologic sample. Arch. Gen. Psychiatry 49, 282-288.
16. Stein, M.B., Chartier, M.J., Hazen, A.L., Kroft, C.D., Chale, R.A., Cot, D., Walker, J.R., 1996. Paroxetine in the treatment of generalized social phobia: Open-label treatment and double-blind placebo-controlled discontinuation. J. Clin. Psychopharmacol. 16, 218-222.
17. van Vliet, I.M., den Boer, J.A., Westenberg, H.G., 1994. Psychopharmacological treatment of social phobia: A double-blind, placebo-controlled study with fluvoxamine. Psychopharmacology 115, 128-134.
18. Versiani, M., Nardi, A.E., Mundim, F.D., Alves, A.B., Liebowitz, M.R., Amrein, R., 1992. Pharmacotherapy of social phobia. Br. J. Psychiatry 161, 353-360.
19. Weiller, E., Bisserbe, J.C., Boyer, P., Lepine, J.P., Lecrubier, Y., 1996. Social phobia in general health care. An unrecognised undertreated disabling disorder. Br. J. Psychiatry 168, 169-174.
20. Zohar, J., Judge, R., 1996. Paroxetine versus clomipramine in the treatment of obsessive compulsive disorder. Br. J. Psychiatry 169, 468-474.